Yin DL - Search Results

1

Portal hypertension resulted from paroxysmal nocturnal hemoglobinuria: a case report and review of literature.

Yin DL, Liu LX, Zhang SG, Tian LT, Lu ZY, Jiang HC. Yin DL, et al. Int J Hematol. 2009 Apr;89(3):302-304. doi: 10.1007/s12185-009-0287-4. Epub 2009 Mar 26. Int J Hematol. 2009. PMID: 19319631 Review.

2

Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma.

Song X, Wang JB, Yin DL, Yang HY, Liu LX, Jiang HC. Song X, et al. Among authors: yin dl. Chin Med J (Engl). 2009 Nov 5;122(21):2636-42. Chin Med J (Engl). 2009. PMID: 19951584

3

PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.

Zheng T, Meng X, Wang J, Chen X, Yin D, Liang Y, Song X, Pan S, Jiang H, Liu L. Zheng T, et al. J Cell Biochem. 2010 Sep 1;111(1):218-28. doi: 10.1002/jcb.22691. J Cell Biochem. 2010. PMID: 20506484

4

Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma.

Liang Y, Yin D, Hou L, Zheng T, Wang J, Meng X, Lu Z, Song X, Pan S, Jiang H, Liu L. Liang Y, et al. PLoS One. 2011;6(8):e23908. doi: 10.1371/journal.pone.0023908. Epub 2011 Aug 25. PLoS One. 2011. PMID: 21901145 Free PMC article.

5

Expression and prognostic value of ING3 in human primary hepatocellular carcinoma.

Yang HY, Liu HL, Tian LT, Song RP, Song X, Yin DL, Liang YJ, Qu LD, Jiang HC, Liu JR, Liu LX. Yang HY, et al. Among authors: yin dl. Exp Biol Med (Maywood). 2012 Apr;237(4):352-61. doi: 10.1258/ebm.2011.011346. Exp Biol Med (Maywood). 2012. PMID: 22550337

6

Precise hepatectomy guided by minimally invasive surgery: a novel strategy for liver resection.

Yin DL, Jiang HC, Liang YJ, Meng XZ, Wang JB, Zheng TS, Liu LX. Yin DL, et al. Hepatogastroenterology. 2012 Sep;59(118):1951-9. doi: 10.5754/hge10815. Hepatogastroenterology. 2012. PMID: 22819915

7

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.

Liang Y, Zheng T, Song R, Wang J, Yin D, Wang L, Liu H, Tian L, Fang X, Meng X, Jiang H, Liu J, Liu L. Liang Y, et al. Hepatology. 2013 May;57(5):1847-57. doi: 10.1002/hep.26224. Epub 2013 Mar 14. Hepatology. 2013. PMID: 23299930

8

Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.

Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, Song R, Song X, Lu Z, Qi S, Liu J, Sun B, Xie C, Pan S, Li Y, Luo X, Li S, Fang X, Bhatta N, Jiang H, Liu L. Zheng T, et al. Hepatology. 2014 Mar;59(3):935-46. doi: 10.1002/hep.26705. Epub 2014 Jan 29. Hepatology. 2014. PMID: 24037855

9

LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.

Song X, Wang J, Zheng T, Song R, Liang Y, Bhatta N, Yin D, Pan S, Liu J, Jiang H, Liu L. Song X, et al. Mol Cancer. 2013 Oct 5;12(1):114. doi: 10.1186/1476-4598-12-114. Mol Cancer. 2013. PMID: 24093956 Free PMC article.

10

Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.

Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L. Zheng T, et al. Mol Cancer. 2014 May 31;13:133. doi: 10.1186/1476-4598-13-133. Mol Cancer. 2014. PMID: 24884809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters